Jazz Pharmaceuticals (JAZZ) 169.69 $JAZZ
S&P 500 Closes At Record High As Oil Stocks Rebound
at Investor's Business Daily - Fri Feb 13, 4:07PM CST
Stocks rose Friday, with the S&P 500 closing at a record high on strong earnings reports and better-than-expected German economic growth. The Nasdaq led the gains, rising 0.7%, while the S&P climbed 0.4% and the Dow Jones industrial average edged up...
VDSI: 27.86 (+2.69), VIPS: 21.80 (+0.36), RAX: 50.01 (+0.24), PXD: 157.85 (+9.71), CYBR: 52.52 (+6.83), JAZZ: 169.69 (+6.89), FRGI: 61.80 (-0.33)
Jazz Pharmaceuticals to Present Data on Defibrotide, an Investigational Treatment, in Patients with Hepatic Veno-Occlusive Disease (VOD) at BMT Tandem Meetings
PR Newswire Europe - Thu Feb 12, 7:31AM CST
- Three Oral Presentations Provide New Analyses of the Efficacy and Safety of Defibrotide in Patients with VOD, Including Post-Hoc Sub-Group Analyses in Children, Adults, and Allograft and Autograft Recipients
JAZZ: 169.69 (+6.89)
Jazz Pharmaceuticals to Report 2014 Fourth Quarter and Full Year Financial Results on February 24, 2015
PR Newswire Europe - Tue Feb 10, 3:06PM CST
Jazz Pharmaceuticals plc today announced that it will report its 2014 fourth quarter and full year financial results on Tuesday, February 24, 2015, after the close of the financial markets. Company management will host a live audio webcast immediately following the announcement at 4:30 p.m. EST/9:30 p.m. GMT to discuss fourth quarter and full year 2014 financial results and provide a business and financial update and guidance for 2015 financial results.
JAZZ: 169.69 (+6.89)
17 Healthcare Companies To Consider Based On Patent Dynamics And IP/Patent Indexes
Innovalpha - Seeking Alpha - Tue Feb 10, 8:08AM CST
Introduction We will present here a few healthcare stocks that have been recently selected by our IP models. As already explained in our SA article " Patent Dynamics And Stock Performance ", Innovalpha has developed proprietary IP and...
SGYP: 2.98 (unch), INSM: 17.40 (+0.69), RNN: 0.75 (+0.01), ZSPH: 46.77 (+3.42), RDHL: 12.69 (+0.04), ASPX: 65.76 (+2.76), ACUR: 0.55 (+0.01), XNPT: 6.69 (-0.21), SPNC: 33.69 (-0.06), CORI: 7.00 (-0.05), SAGE: 41.03 (-0.07), EBIO: 10.13 (+0.05), HAE: 42.94 (-0.59), JAZZ: 169.69 (+6.89), ICPT: 209.12 (+7.12), NVDQ: 15.12 (+0.51)
6 Big Pharmaceutical Companies You Don't Want In Your Portfolio
at The Street - Tue Feb 10, 7:17AM CST
Which big pharmaceutical stocks should investors stay away from in 2015?
MNK: 115.01 (+2.51), ENDP: 84.01 (+1.12), JAZZ: 169.69 (+6.89), AZN: 69.96 (+0.20), SLXP: 152.35 (+3.17), GSK: 47.94 (+1.99)
Healthcare stock screen of the month: Accelerating after-tax margins
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 11:21AM CST
MNK: 115.01 (+2.51), BIIB: 391.66 (-0.45), VRX: 167.00 (-0.50), BCR: 175.38 (+0.50), EVHC: 36.20 (-0.09), TMO: 127.61 (+0.78), CAH: 86.08 (+0.04), UTHR: 151.11 (+3.59), ILMN: 198.54 (+1.81), ACOR: 36.14 (-0.51), LCI: 57.78 (-0.91), JAZZ: 169.69 (+6.89), SHPG: 239.82 (+6.11), CPHD: 59.62 (+0.72), SYK: 94.51 (+1.14)
Jazz Pharmaceuticals: Upside Opportunities
Max Grigoryev - at Seeking Alpha - Thu Jan 29, 7:55AM CST
JAZZ: 169.69 (+6.89)
IBD 50 Turns In Solid Week As Market Uptrend Resumes
at Investor's Business Daily - Fri Jan 23, 5:34PM CST
If the market has shown us one thing in recent weeks, it's that conditions can turn on a dime. The Nasdaq notched a follow-through on Jan. 8, but a distribution day on Jan. 12 called the viability of the rally into question. On Thursday, the Nasdaq...
BIIB: 391.66 (-0.45), VRX: 167.00 (-0.50), V: 269.63 (-1.28), PCYC: 163.28 (+0.23), FB: 75.74 (-0.49), JAZZ: 169.69 (+6.89), HDB: 58.41 (-0.98), ILMN: 198.54 (+1.81), TSM: 24.84 (+0.37), NXPI: 84.79 (-0.60), ULTA: 136.66 (+0.59)
Jazz: After 18% In Gains, Earnings Lurk
Feria Investor - at Seeking Alpha - Thu Jan 22, 6:54PM CST
JAZZ: 169.69 (+6.89)
Top World Stocks Close In On Buy Points, New Highs
at Investor's Business Daily - Thu Jan 22, 5:36PM CST
The long, slow lead-in to Europe's quantitative easing effort climaxed Thursday with the European Central Bank announcing it would launch a nearly $70 billion-per-month bond buying program in March. Europe's markets jumped to considerable gains, with...
MNK: 115.01 (+2.51), RDWR: 20.85 (+0.42), ACT: 285.37 (+3.71), NTES: 112.99 (-0.49), BIDU: 212.13 (+7.11), JAZZ: 169.69 (+6.89), HDB: 58.41 (-0.98), SIMO: 29.08 (-0.39)
SmarTrend Watching for Potential Pullback in Shares of Jazz Pharmaceuticals After 3.17% Gain
Comtex SmarTrend(R) - Wed Jan 21, 4:46PM CST
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $167.68 to a high of $177.01. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of $170.68 on volume of 904,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JAZZ: 169.69 (+6.89)
Stocks Hold Near Day's Highs; Actavis Retakes Buy Point
at Investor's Business Daily - Wed Jan 21, 12:19PM CST
Stocks remained near their session highs Wednesday afternoon. The Nasdaq and the S&P 500 were up 0.5% each. Meanwhile, the Dow Jones industrial average edged up 0.2%. Volume was still tracking mixed in the stock market today. Nasdaq trade was running...
ACT: 285.37 (+3.71), JAZZ: 169.69 (+6.89), TM: 132.49 (+0.67), LUV: 43.30 (-0.20)
Insider Trading Alert - MJN, JAZZ And TTGT Traded By Insiders
at The Street - Fri Jan 16, 9:30AM CST
Stocks with insider trader activity include MJN, JAZZ and TTGT
MJN: 101.89 (+2.32), JAZZ: 169.69 (+6.89), TTGT: 11.90 (+0.60)
Flamel sinks on Jazz Pharma patent ruling
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 10:51AM CST
FLML: 14.15 (+0.15), B: 37.40 (+0.44), JAZZ: 169.69 (+6.89)
Jazz Pharma sees 2014 revenues at top end of guidance
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 10:13AM CST
JAZZ: 169.69 (+6.89)
InsiderInsights.com Daily Round Up 1/7/15: RM, OPK, NHF, MLNK
InsiderInsights - at Seeking Alpha - Thu Jan 08, 3:26PM CST
CCO: 9.46 (+0.07), VVUS: 2.68 (+0.13), NU: 51.02 (-1.28), TGTX: 13.13 (-0.19), MLNK: 3.78 (+0.04), RM: 15.88 (+0.96), SRE: 105.56 (-1.11), SHLD: 35.70 (+2.32), GOOG: 549.01 (+6.08), LQ: 21.59 (unch), PPT: 5.23 (+0.01), CTRE: 13.46 (+0.26), BH: 416.41 (-1.55), PLUS: 80.17 (-0.21), OPK: 13.80 (-0.28), JAZZ: 169.69 (+6.89), NHF: 11.69 (+0.08), TWTR: 48.50 (+0.55), CRM: 62.85 (+1.59)
Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 12
PR Newswire Europe - Mon Jan 05, 3:05PM CST
Jazz Pharmaceuticals plc today announced that the company will be webcasting its corporate presentation at the 33(rd) Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
JPM: 59.67 (+0.10), JAZZ: 169.69 (+6.89)
S&P 500 Closes At Record High As Oil Stocks Rebound
at Investor's Business Daily - Fri Feb 13, 4:07PM CST
Stocks rose Friday, with the S&P 500 closing at a record high on strong earnings reports and better-than-expected German economic growth. The Nasdaq led the gains, rising 0.7%, while the S&P climbed 0.4% and the Dow Jones industrial average edged up...
VDSI: 27.86 (+2.69), VIPS: 21.80 (+0.36), RAX: 50.01 (+0.24), PXD: 157.85 (+9.71), CYBR: 52.52 (+6.83), JAZZ: 169.69 (+6.89), FRGI: 61.80 (-0.33)
Jazz Pharmaceuticals to Present Data on Defibrotide, an Investigational Treatment, in Patients with Hepatic Veno-Occlusive Disease (VOD) at BMT Tandem Meetings
PR Newswire Europe - Thu Feb 12, 7:31AM CST
- Three Oral Presentations Provide New Analyses of the Efficacy and Safety of Defibrotide in Patients with VOD, Including Post-Hoc Sub-Group Analyses in Children, Adults, and Allograft and Autograft Recipients
JAZZ: 169.69 (+6.89)
Jazz Pharmaceuticals to Report 2014 Fourth Quarter and Full Year Financial Results on February 24, 2015
PR Newswire Europe - Tue Feb 10, 3:06PM CST
Jazz Pharmaceuticals plc today announced that it will report its 2014 fourth quarter and full year financial results on Tuesday, February 24, 2015, after the close of the financial markets. Company management will host a live audio webcast immediately following the announcement at 4:30 p.m. EST/9:30 p.m. GMT to discuss fourth quarter and full year 2014 financial results and provide a business and financial update and guidance for 2015 financial results.
JAZZ: 169.69 (+6.89)
17 Healthcare Companies To Consider Based On Patent Dynamics And IP/Patent Indexes
Innovalpha - Seeking Alpha - Tue Feb 10, 8:08AM CST
Introduction We will present here a few healthcare stocks that have been recently selected by our IP models. As already explained in our SA article " Patent Dynamics And Stock Performance ", Innovalpha has developed proprietary IP and...
SGYP: 2.98 (unch), INSM: 17.40 (+0.69), RNN: 0.75 (+0.01), ZSPH: 46.77 (+3.42), RDHL: 12.69 (+0.04), ASPX: 65.76 (+2.76), ACUR: 0.55 (+0.01), XNPT: 6.69 (-0.21), SPNC: 33.69 (-0.06), CORI: 7.00 (-0.05), SAGE: 41.03 (-0.07), EBIO: 10.13 (+0.05), HAE: 42.94 (-0.59), JAZZ: 169.69 (+6.89), ICPT: 209.12 (+7.12), NVDQ: 15.12 (+0.51)
6 Big Pharmaceutical Companies You Don't Want In Your Portfolio
at The Street - Tue Feb 10, 7:17AM CST
Which big pharmaceutical stocks should investors stay away from in 2015?
MNK: 115.01 (+2.51), ENDP: 84.01 (+1.12), JAZZ: 169.69 (+6.89), AZN: 69.96 (+0.20), SLXP: 152.35 (+3.17), GSK: 47.94 (+1.99)
Healthcare stock screen of the month: Accelerating after-tax margins
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 11:21AM CST
MNK: 115.01 (+2.51), BIIB: 391.66 (-0.45), VRX: 167.00 (-0.50), BCR: 175.38 (+0.50), EVHC: 36.20 (-0.09), TMO: 127.61 (+0.78), CAH: 86.08 (+0.04), UTHR: 151.11 (+3.59), ILMN: 198.54 (+1.81), ACOR: 36.14 (-0.51), LCI: 57.78 (-0.91), JAZZ: 169.69 (+6.89), SHPG: 239.82 (+6.11), CPHD: 59.62 (+0.72), SYK: 94.51 (+1.14)
Jazz Pharmaceuticals: Upside Opportunities
Max Grigoryev - at Seeking Alpha - Thu Jan 29, 7:55AM CST
JAZZ: 169.69 (+6.89)
IBD 50 Turns In Solid Week As Market Uptrend Resumes
at Investor's Business Daily - Fri Jan 23, 5:34PM CST
If the market has shown us one thing in recent weeks, it's that conditions can turn on a dime. The Nasdaq notched a follow-through on Jan. 8, but a distribution day on Jan. 12 called the viability of the rally into question. On Thursday, the Nasdaq...
BIIB: 391.66 (-0.45), VRX: 167.00 (-0.50), V: 269.63 (-1.28), PCYC: 163.28 (+0.23), FB: 75.74 (-0.49), JAZZ: 169.69 (+6.89), HDB: 58.41 (-0.98), ILMN: 198.54 (+1.81), TSM: 24.84 (+0.37), NXPI: 84.79 (-0.60), ULTA: 136.66 (+0.59)
Jazz: After 18% In Gains, Earnings Lurk
Feria Investor - at Seeking Alpha - Thu Jan 22, 6:54PM CST
JAZZ: 169.69 (+6.89)
Top World Stocks Close In On Buy Points, New Highs
at Investor's Business Daily - Thu Jan 22, 5:36PM CST
The long, slow lead-in to Europe's quantitative easing effort climaxed Thursday with the European Central Bank announcing it would launch a nearly $70 billion-per-month bond buying program in March. Europe's markets jumped to considerable gains, with...
MNK: 115.01 (+2.51), RDWR: 20.85 (+0.42), ACT: 285.37 (+3.71), NTES: 112.99 (-0.49), BIDU: 212.13 (+7.11), JAZZ: 169.69 (+6.89), HDB: 58.41 (-0.98), SIMO: 29.08 (-0.39)
SmarTrend Watching for Potential Pullback in Shares of Jazz Pharmaceuticals After 3.17% Gain
Comtex SmarTrend(R) - Wed Jan 21, 4:46PM CST
Jazz Pharmaceuticals (NASDAQ:JAZZ) traded in a range yesterday that spanned from a low of $167.68 to a high of $177.01. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of $170.68 on volume of 904,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JAZZ: 169.69 (+6.89)
Stocks Hold Near Day's Highs; Actavis Retakes Buy Point
at Investor's Business Daily - Wed Jan 21, 12:19PM CST
Stocks remained near their session highs Wednesday afternoon. The Nasdaq and the S&P 500 were up 0.5% each. Meanwhile, the Dow Jones industrial average edged up 0.2%. Volume was still tracking mixed in the stock market today. Nasdaq trade was running...
ACT: 285.37 (+3.71), JAZZ: 169.69 (+6.89), TM: 132.49 (+0.67), LUV: 43.30 (-0.20)
Insider Trading Alert - MJN, JAZZ And TTGT Traded By Insiders
at The Street - Fri Jan 16, 9:30AM CST
Stocks with insider trader activity include MJN, JAZZ and TTGT
MJN: 101.89 (+2.32), JAZZ: 169.69 (+6.89), TTGT: 11.90 (+0.60)
Flamel sinks on Jazz Pharma patent ruling
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 10:51AM CST
FLML: 14.15 (+0.15), B: 37.40 (+0.44), JAZZ: 169.69 (+6.89)
Jazz Pharma sees 2014 revenues at top end of guidance
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 10:13AM CST
JAZZ: 169.69 (+6.89)
InsiderInsights.com Daily Round Up 1/7/15: RM, OPK, NHF, MLNK
InsiderInsights - at Seeking Alpha - Thu Jan 08, 3:26PM CST
CCO: 9.46 (+0.07), VVUS: 2.68 (+0.13), NU: 51.02 (-1.28), TGTX: 13.13 (-0.19), MLNK: 3.78 (+0.04), RM: 15.88 (+0.96), SRE: 105.56 (-1.11), SHLD: 35.70 (+2.32), GOOG: 549.01 (+6.08), LQ: 21.59 (unch), PPT: 5.23 (+0.01), CTRE: 13.46 (+0.26), BH: 416.41 (-1.55), PLUS: 80.17 (-0.21), OPK: 13.80 (-0.28), JAZZ: 169.69 (+6.89), NHF: 11.69 (+0.08), TWTR: 48.50 (+0.55), CRM: 62.85 (+1.59)
Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 12
PR Newswire Europe - Mon Jan 05, 3:05PM CST
Jazz Pharmaceuticals plc today announced that the company will be webcasting its corporate presentation at the 33(rd) Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
JPM: 59.67 (+0.10), JAZZ: 169.69 (+6.89)
